BioSig Executes Agreement with Bellin Health for the Acquisition of its PURE EP™ TechnologyGlobeNewsWire • 01/10/23
Update: BioSig's PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in SingaporeGlobeNewsWire • 12/14/22
BioSig's PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in SingaporeGlobeNewsWire • 12/14/22
BioSig's PURE EP™ System Highlighted in the Journal of Atrial Fibrillation & ElectrophysiologyGlobeNewsWire • 12/06/22
BioSig Signs Master Research Agreement with Cleveland Clinic to Explore Expanded Applications for its Digital Signal Processing TechnologyGlobeNewsWire • 10/24/22
BioSig Executes Purchase Agreement with Methodist Hospital, San Antonio and Expands Customer BaseGlobeNewsWire • 10/07/22
Bluejay Diagnostics (NASDAQ:BJDX), BioSig Technologies (NASDAQ:BSGM) – Sharps Technology And 2 Other Stocks Under $2 Insiders Are Aggressively BuyingBenzinga • 09/08/22
(BSGM), (LDI) – BioSig Technologies, Reliance Global Group And 2 Other Penny Stocks Insiders Are Aggressively BuyingBenzinga • 09/01/22
BioSig Strengthens Marketing and Sales Teams, Appoints National Account Executives to Scale Commercial GrowthGlobeNewsWire • 08/30/22
BioSig Places Second PURE EP™ System For Evaluation at Cleveland Clinic a Leading Medical Center of ExcellenceGlobeNewsWire • 08/24/22
BioSig's Cardiac Signal Processing Technology To Be Featured at Kansas City Heart Rhythm Symposium 2022GlobeNewsWire • 08/17/22
BioSig Announces Physician-Initiated Research Protocol at The Kansas City Heart Rhythm InstituteGlobeNewsWire • 07/21/22
BioSig Technologies says Kansas City Heart Institute signs purchase agreement for its PURE EP SystemProactive Investors • 07/07/22
BioSig Announces Purchase Agreement with Kansas City Heart Rhythm Institute at Overland Park Regional Medical CenterGlobeNewsWire • 07/07/22
BioSig Technologies gets repeat 'Outperform' tag, $4 price target from Noble CapitalProactive Investors • 06/30/22